4 research outputs found
Relative risks for primary and secondary outcomes of patients prescribed escitalopram compared to the referent antidepressants (paroxetine or sertraline).
<p>Relative risks for primary and secondary outcomes of patients prescribed escitalopram compared to the referent antidepressants (paroxetine or sertraline).</p
Baseline characteristics for the escitalopram cohort (pre and post weighting).
<p>Baseline characteristics for the escitalopram cohort (pre and post weighting).</p
Subgroup analyses of the association between citalopram prescription and the risk of a hospital encounter with ventricular arrhythmia or all-cause mortality.
<p><b>Abbreviations:</b> Coronary artery disease (CAD), Congestive heart failure (CHF), Confidence interval (CI).</p
Baseline characteristics for the citalopram cohort (pre and post weighting).
<p>Baseline characteristics for the citalopram cohort (pre and post weighting).</p